Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of CT, PET-CT, and MRI in ovarian cancer.

Literature DB >> 34415198

The role of CT, PET-CT, and MRI in ovarian cancer.

Maurits Peter Engbersen¹, Willemien Van Driel², Doenja Lambregts¹, Max Lahaye¹.

Abstract

New treatment developments in ovarian cancer have led to a renewed interest in staging advanced ovarian cancer. The treatment of females with ovarian cancer patients has a strong multidisciplinary character with an essential role for the radiologist. This review aims to provide an overview of the current position of CT, positron emission tomography-CT, and MRI in ovarian cancer and how imaging can be used to guide multidisciplinary team discussions.

Entities: Chemical

Mesh：

Year: 2021 PMID： 34415198 PMCID： PMC9327775 DOI： 10.1259/bjr.20210117

Source DB: PubMed Journal: Br J Radiol ISSN： 0007-1285 Impact factor: 3.629

70 in total

1. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

Authors: Philipp Harter; Jalid Sehouli; Domenica Lorusso; Alexander Reuss; Ignace Vergote; Christian Marth; Jae-Weon Kim; Francesco Raspagliesi; Björn Lampe; Giovanni Aletti; Werner Meier; David Cibula; Alexander Mustea; Sven Mahner; Ingo B Runnebaum; Barbara Schmalfeldt; Alexander Burges; Rainer Kimmig; Giovanni Scambia; Stefano Greggi; Felix Hilpert; Annette Hasenburg; Peter Hillemanns; Giorgio Giorda; Ingo von Leffern; Carmen Schade-Brittinger; Uwe Wagner; Andreas du Bois
Journal: N Engl J Med Date: 2019-02-28 Impact factor: 91.245

2. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.

Authors: Milena Sant; Maria Dolores Chirlaque Lopez; Roberto Agresti; Maria José Sánchez Pérez; Bernd Holleczek; Magdalena Bielska-Lasota; Nadya Dimitrova; Kaire Innos; Alexander Katalinic; Hilde Langseth; Nerea Larrañaga; Silvia Rossi; Sabine Siesling; Pamela Minicozzi
Journal: Eur J Cancer Date: 2015-09-26 Impact factor: 9.162

3. 18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.

Authors: Nicolas Aide; Kathryn Kinross; Carleen Cullinane; Peter Roselt; Kelly Waldeck; Oliver Neels; Donna Dorow; Grant McArthur; Rodney J Hicks
Journal: J Nucl Med Date: 2010-09-16 Impact factor: 10.057

Review 4. Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models.

Authors: Marianne Jetske Rutten; Roelien van de Vrie; Annemarie Bruining; Anje M Spijkerboer; Ben Willem Mol; Gemma Georgette Kenter; Marrije Renate Buist
Journal: Int J Gynecol Cancer Date: 2015-03 Impact factor: 3.437

5. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.

Authors: I van 't Sant; W J van Eden; M P Engbersen; N F M Kok; K Woensdregt; D M J Lambregts; S Shanmuganathan; R G H Beets-Tan; A G J Aalbers; M J Lahaye
Journal: Br J Surg Date: 2018-10-24 Impact factor: 6.939

6. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).

Authors: Anna Fagotti; Maria Gabriella Ferrandina; Giuseppe Vizzielli; Tina Pasciuto; Francesco Fanfani; Valerio Gallotta; Pasquale Alessandro Margariti; Vito Chiantera; Barbara Costantini; Salvatore Gueli Alletti; Francesco Cosentino; Giovanni Scambia
Journal: Int J Gynecol Cancer Date: 2020-10-07 Impact factor: 3.437

Review 7. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis.

Authors: Ping Gu; Ling-Ling Pan; Shu-Qi Wu; Li Sun; Gang Huang
Journal: Eur J Radiol Date: 2008-04-18 Impact factor: 3.528

Review 8. Patient Selection for Cytoreductive Surgery.

Authors: Travis E Grotz; Keith F Fournier; Paul F Mansfield
Journal: Surg Oncol Clin N Am Date: 2018-07 Impact factor: 3.495

9. Ultra-High-b-Value Kurtosis Imaging for Noninvasive Tissue Characterization of Ovarian Lesions.

Authors: Theresa Mokry; Anna Mlynarska-Bujny; Tristan Anselm Kuder; Felix Christian Hasse; Robert Hog; Markus Wallwiener; Christine Dinkic; Janina Brucker; Peter Sinn; Regula Gnirs; Hans-Ulrich Kauczor; Heinz-Peter Schlemmer; Joachim Rom; Sebastian Bickelhaupt
Journal: Radiology Date: 2020-06-16 Impact factor: 11.105